Company Analysis

Amphastar Pharmaceuticals, Inc. (AMPH)

Nasdaq: AMPH · Pharmaceutical Preparations · Rancho Cucamonga, CA · filing with the SEC since 2005
Grade6.5
◀ Past 7.8● Present 7.4▶ Future 4.1

Who runs Amphastar Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Zhang Jack Y.
CEO & CHIEF SCIENTIFIC OFFICER. First filing Jun 2014, latest Mar 17, 2026, 11 filings in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
17 people on the record since 2014
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Peters William JCFO, EVP & TREASURERJun 2014Nov 6, 20264 · $1.1M
Zhou RongSENIOR EVP, PRODUCTION CENTERJun 2015Sep 17, 20263 · $600,000
Gerst Diane G.EVP, QA & Regulatory AffairsJun 2014Jun 3, 2026none
Zhang Jack Y.CEO & CHIEF SCIENTIFIC OFFICERJun 2014Mar 17, 2026none
Luo Mary Z.COO, Chief Scientist, ChairmanJun 2014Mar 17, 2026none
Liawatidewi YakobEVP CORP ADMIN CENTERJun 2018Mar 17, 2026none
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
NameRoleFirst filingLatest filingSales, 12 months
Prins Richard KdirectorJun 2014Aug 12, 20262 · $300,000
Pierce Anthony TdirectorJul 2026Jul 13, 2026none
Deflin GayledirectorJun 2021Jun 3, 2026none
Gaugh David RusselldirectorJul 2025Jun 3, 2026none
Lee HowarddirectorJun 2014Jun 3, 2026none
Zasloff Michael AdirectorJun 2014Jun 3, 2026none
Petersen Floyd F.directorJun 2014Dec 15, 20253 · $500,000
Earlier names on the record5, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AMPH · research, not advice